Curiously, analysis of patient sentinel lymph nodes from melanoma patients showed that CCL21 mRNA levels were higher in non-metastatic samples compared to lower CCL21 expression in patients with metastatic tumors, suggesting that CCL21 levels are downregulated during metastatic progression, possibly to reduce recruitment of CCR7-responsive immune cells [228]. Here, CCL21 is linked to melanoma.